Denosumab

CAT:
804-HY-P9958-01
Size:
1 mg

For Laboratory Research Only. Not for Clinical or Personal Use.

  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Denosumab - image 1

Denosumab

  • Description:

    Denosumab is a human monoclonal antibody that targets the protein RANKL. Denosumab binds to the receptor activator of nuclear factor kappa-B ligand (RANKL) and prevents its binding to the RANK receptor (KD of 0.003 nM for human RANKL) . Denosumab promotes proliferation and spermatogenesis. Denosumab prevents bone resorption through inhibition of the NF-κB pathway. Denosumab can be used in bone-related studies[1][2][3][4][5][6][7].
  • Product Name Alternative:

    AMG-162
  • UNSPSC:

    12352203
  • Target:

    Apoptosis; Caspase; NF-κB; RANKL/RANK
  • Type:

    Inhibitory Antibodies
  • Related Pathways:

    Apoptosis; NF-κB
  • Applications:

    Cancer-programmed cell death
  • Field of Research:

    Cancer; Endocrinology
  • Assay Protocol:

    https://www.medchemexpress.com/denosumab.html
  • Purity:

    99.10
  • Solubility:

    H2O
  • Smiles:

    [Denosumab]
  • Molecular Formula:

    C6404H9908N1724O2004S50
  • Molecular Weight:

    (145.16 kDa)
  • References & Citations:

    [1]1. Moen MD, et al. Denosumab: a review of its use in the treatment of postmenopausal osteoporosis. Drugs Aging. 2011;28 (1) :63-82. |[2]2. Kendler DL, et al. Denosumab in the Treatment of Osteoporosis: 10 Years Later: A Narrative Review. Adv Ther. 2022 Jan;39 (1) :58-74. |[3]3. Dell'Aquila E, et al. Denosumab for cancer-related bone loss. Expert Opin Biol Ther. 2020 Nov;20 (11) :1261-1274. |[4]4. Mosch A, et al. Physiological concentrations of denosumab enhance osteogenic differentiation in human mesenchymal stem cells of the jaw bone. Arch Oral Biol. 2019 May;101:23-29.|[5]5. Shangguan L, et al. Denosumab ameliorates osteoarthritis by protecting cartilage against degradation and modulating subchondral bone remodeling. Regen Ther. 2024 Mar 26;27:181-190. |[6]6. Kondegowda NG, et al. Osteoprotegerin and Denosumab Stimulate Human Beta Cell Proliferation through Inhibition of the Receptor Activator of NF-κB Ligand Pathway. Cell Metab. 2015 Jul 7;22 (1) :77-85. |[7]7. Andreassen CH, et al. Denosumab stimulates spermatogenesis in infertile men with preserved Sertoli cell capacity. Cell Rep Med. 2024 Oct 15;5 (10) :101783.
  • Shipping Conditions:

    Blue Ice
  • Storage Conditions:

    Store at 4°C for 2 years, do not freeze
  • Scientific Category:

    Inhibitory Antibodies
  • Clinical Information:

    Launched
  • Isoform:

    Caspase 3
  • CAS Number:

    615258-40-7